Advertisement

Topics

ProteoTech, Inc. Company Profile

04:17 EDT 25th June 2018 | BioPortfolio

Company Description: ProteoTech Inc. is a world leader in research and development of new therapeutics derived from proteoglycan and amyloid technologies for the treatment of major human diseases. ProteoTech is developing human therapeutics for Alzheimer's, Parkinson's, prion diseases, type 2 diabetes, and systemic amyloidosis. In 1997, ProteoTech was granted a worldwide exclusive license from the University of Washington to certain proteoglycan technologies including new methods and therapeutics for the treatment of human amyloid diseases. The Company has been successful in discovering 3 proprietary classes of compounds that inhibit and disrupt the amyloid fibril process, which include (1) small molecule compounds and synthetic analogs (including NCE's), (2) small peptides and mimetics, and (3) glycosaminoglycan/ carbohydrate therapeutics. The Company believes that specific and newly identified compounds within these classes will be successful in preventing the progression of amyloid diseases.

Location

12026 - 115th Avenue N.E.
Kirkland
Washington
98034
United States of America

Contact

Phone: (425) 823-0400


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

ProteoTech Inc.

ProteoTech is a privately-held, drug development company that utilizes its amyloid expertise to discover and develop new drugs for treating misfolded protein disorders and amyloid...

ProteoTech, Inc.

Company Description: ProteoTech Inc. is a world leader in research and development of new therapeutics derived from proteoglycan and amyloid technologies for the treatment of major human diseases. Pro...

More Information about "ProteoTech, Inc." on BioPortfolio

We have published hundreds of ProteoTech, Inc. news stories on BioPortfolio along with dozens of ProteoTech, Inc. Clinical Trials and PubMed Articles about ProteoTech, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ProteoTech, Inc. Companies in our database. You can also find out about relevant ProteoTech, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...


Corporate Database Quicklinks



Searches Linking to this Company Record